DE69005062T2 - Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie. - Google Patents

Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.

Info

Publication number
DE69005062T2
DE69005062T2 DE90309638T DE69005062T DE69005062T2 DE 69005062 T2 DE69005062 T2 DE 69005062T2 DE 90309638 T DE90309638 T DE 90309638T DE 69005062 T DE69005062 T DE 69005062T DE 69005062 T2 DE69005062 T2 DE 69005062T2
Authority
DE
Germany
Prior art keywords
skin damage
radiotherapy
prevention
treatment
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE90309638T
Other languages
English (en)
Other versions
DE69005062D1 (de
Inventor
David Frederick Horrobin
Catherine Ann Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10662681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69005062(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of DE69005062D1 publication Critical patent/DE69005062D1/de
Application granted granted Critical
Publication of DE69005062T2 publication Critical patent/DE69005062T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Amplifiers (AREA)
  • Bipolar Transistors (AREA)
DE90309638T 1989-09-07 1990-09-04 Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie. Revoked DE69005062T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898920228A GB8920228D0 (en) 1989-09-07 1989-09-07 Fatty acid therapy

Publications (2)

Publication Number Publication Date
DE69005062D1 DE69005062D1 (de) 1994-01-20
DE69005062T2 true DE69005062T2 (de) 1994-05-05

Family

ID=10662681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90309638T Revoked DE69005062T2 (de) 1989-09-07 1990-09-04 Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.

Country Status (14)

Country Link
EP (1) EP0416855B1 (de)
JP (1) JPH0399013A (de)
KR (1) KR910005858A (de)
AT (1) ATE98121T1 (de)
AU (1) AU633618B2 (de)
CA (1) CA2024724A1 (de)
DE (1) DE69005062T2 (de)
DK (1) DK0416855T3 (de)
FI (1) FI904403A0 (de)
GB (1) GB8920228D0 (de)
HK (1) HK74694A (de)
IE (1) IE63449B1 (de)
NZ (1) NZ235203A (de)
ZA (1) ZA907040B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
GB9621373D0 (en) * 1996-10-14 1996-12-04 Scotia Holdings Plc Fatty acid treatment
AU5928898A (en) * 1997-01-24 1998-08-18 Regents Of The University Of California, The Use of fxr, pparalpha and lxralpha activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
US5855893A (en) * 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
FR2765482B1 (fr) * 1997-07-07 2000-12-08 Oreal Utilisation de l'acide y-linolenique pour prevenir le stress oxydatif
GB9724802D0 (en) * 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
CA2599112C (en) 2005-02-14 2013-10-22 Suntory Limited Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205076A (en) * 1982-08-09 1985-04-30 Univ California Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
EP0309086A1 (de) * 1987-09-07 1989-03-29 Efamol Holdings Plc Behandlung der männlichen Glatze und von unerwünschtem Haarwuchs
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0416855B1 (de) 1993-12-08
KR910005858A (ko) 1991-04-27
IE903221A1 (en) 1991-03-13
DE69005062D1 (de) 1994-01-20
AU6213590A (en) 1991-03-14
ATE98121T1 (de) 1993-12-15
FI904403A0 (fi) 1990-09-06
CA2024724A1 (en) 1991-03-08
DK0416855T3 (da) 1994-02-14
GB8920228D0 (en) 1989-10-18
ZA907040B (en) 1991-06-26
NZ235203A (en) 1997-06-24
EP0416855A3 (en) 1991-06-12
JPH0399013A (ja) 1991-04-24
HK74694A (en) 1994-08-05
IE63449B1 (en) 1995-04-19
AU633618B2 (en) 1993-02-04
EP0416855A2 (de) 1991-03-13

Similar Documents

Publication Publication Date Title
DE69005062D1 (de) Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
HUT65754A (en) Process for production of preparations containing complement inhibitors for treatment of inflammatory intestinal-and dermal-diseases
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
DE3881299D1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
ATE163913T1 (de) Ungesättigte aliphatische dicarbonsäuren
SE8703625D0 (sv) New medical use
DE69312579D1 (de) Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit
EP0502925A4 (en) Method and composition for treating inflammatory bowel disorders
DE3886592T2 (de) Präparate zur Behandlung von Beschwerden der Wurzelhaut der Zähne.
ATE228835T1 (de) Verwendung von ranitidin-wismut-zitrat in kombination mit claritromyzin oder claritromyzin und tetrazyklin zur herstellung eines arzneimittels zur behandlung gastrointestinaler beschwerden
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
DE3685052D1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
DE3784738D1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3875637T2 (de) Zusammensetzungen und verfahren zur behandlung von magengeschwueren.
ATE92757T1 (de) Verfahren zur verbesserung der ventilation waehrend des schlafes und behandlung von ventilationsabnormalitaeten, die mit dem schlaf verbunden sind.
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
SU1138167A1 (ru) Способ лечени асептических послеоперационных ран
ATE291431T1 (de) Verwendung von dextrinsulfat zur behandlung von sehr vasculären tumoren
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
RU94020412A (ru) Способ разворота плода
UA8326A1 (uk) Спосіб одержання мазі для лікування псориазу

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8331 Complete revocation